AN2 Therapeutics Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ALMITAS CAPITAL LLC | 02/17/2026 | 1.48 M | $1.69 M | 3.56% | 4.89% |
| VANGUARD GROUP INC | 01/29/2026 | 1.08 M | $1.23 M | 0.00% | 3.57% |
| PFIZER INC | 02/12/2026 | 715.30 K | $815.44 K | 0.00% | 2.36% |
| STONEPINE CAPITAL MANAGEMENT, LLC | 02/13/2026 | 627.67 K | $715.54 K | 11.31% | 2.07% |
| PEAPOD LANE CAPITAL LLC | 01/28/2026 | 593.40 K | $676.47 K | 0.71% | 1.96% |
| BANK OF NOVA SCOTIA | 02/13/2026 | 459.19 K | $523.48 K | 0.00% | 1.52% |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. | 02/13/2026 | 431.76 K | $492.21 K | -5.41% | 1.43% |
| BANK OF MONTREAL /CAN/ | 02/12/2026 | 422.08 K | $481.17 K | 0.00% | 1.39% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 385.31 K | $439.26 K | 0.00% | 1.27% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 338.60 K | $386.00 K | -12.19% | 1.12% |
| BLACKROCK, INC. | 02/12/2026 | 323.34 K | $368.60 K | 0.76% | 1.07% |
| TWO SIGMA ADVISERS, LP | 02/17/2026 | 264.90 K | $301.99 K | -1.12% | 0.87% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 251.88 K | $287.20 K | 1.01% | 0.83% |
| MORGAN STANLEY | 02/13/2026 | 229.77 K | $261.94 K | 20.44% | 0.76% |
| TWO SIGMA INVESTMENTS, LP | 02/17/2026 | 178.52 K | $203.51 K | -20.07% | 0.59% |
| WOODLINE PARTNERS LP | 02/17/2026 | 145.97 K | $166.41 K | 100.00% | 0.48% |
| CITADEL ADVISORS LLC | 02/17/2026 | 115.54 K | $131.71 K | 402.05% | 0.38% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 95.68 K | $109.08 K | 100.00% | 0.32% |
| STATE STREET CORP | 02/13/2026 | 87.00 K | $99.18 K | 0.00% | 0.29% |
| RANGELEY CAPITAL, LLC | 02/17/2026 | 65.00 K | $74.10 K | 0.00% | 0.21% |
| SQUAREPOINT OPS LLC | 02/13/2026 | 61.61 K | $70.24 K | -4.13% | 0.20% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/17/2026 | 59.90 K | $68.29 K | 0.00% | 0.20% |
| UBS GROUP AG | 01/29/2026 | 56.67 K | $64.60 K | -0.05% | 0.19% |
| NORTHERN TRUST CORP | 02/17/2026 | 43.20 K | $49.24 K | 0.00% | 0.14% |
| CAPTRUST FINANCIAL ADVISORS | 02/17/2026 | 40.00 K | $45.60 K | 0.00% | 0.13% |
| PRIVATE ADVISOR GROUP, LLC | 02/17/2026 | 22.50 K | $25.65 K | 0.00% | 0.07% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 22.24 K | $25.35 K | 100.00% | 0.07% |
| JANE STREET GROUP, LLC | 02/12/2026 | 17.94 K | $20.45 K | 100.00% | 0.06% |
| SCHONFELD STRATEGIC ADVISORS LLC | 02/17/2026 | 14.28 K | $16.28 K | 0.00% | 0.05% |
| FEDERATED HERMES, INC. | 02/12/2026 | 11.48 K | $13.09 K | -3.39% | 0.04% |
| VALEO FINANCIAL ADVISORS, LLC | 02/04/2026 | 10.45 K | $11.91 K | 100.00% | 0.03% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/17/2026 | 10.18 K | $11.61 K | 0.00% | 0.03% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/17/2026 | 2.04 K | $2.33 K | -4.14% | 0.01% |
| FMR LLC | 02/17/2026 | 1.20 K | $1.37 K | 20.00% | 0.00% |
| BNP PARIBAS ARBITRAGE, SNC | 02/10/2026 | 303 | $345 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 02/17/2026 | 300 | $342 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 200 | $228 | 0.00% | 0.00% |
| XTX TOPCO LTD | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| ACT ADVISORS, LLC. | 01/14/2026 | 0 | $0 | -100.00% | 0.00% |
| HIGHLINE WEALTH PARTNERS LLC | 01/15/2026 | 0 | $0 | -100.00% | 0.00% |
AN2 Therapeutics Inc institutional Ownership - FAQ's
During the previous two years, 48 institutional investors and hedge funds held shares of AN2 Therapeutics Inc. The most heavily invested institutionals were:
JANE STREET GROUP, LLC: 303,649
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.: 298,166
VANGUARD FIDUCIARY TRUST CO: 137,708
UBS Group AG: 61,392
Peapod Lane Capital LLC: 59,854
Persistent Asset Partners Ltd: 38,155
28.62% of AN2 Therapeutics Inc stock is owned by institutional investors.
Institutional investors have bought a total of 8.55 M shares in the last 24 months. This purchase volume represents approximately $44.88 M in transactions.